
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Protein Kinase Inhibitors - Selectivity or Toxicity?
Moran Grossman, Elaine Adler
Biochemistry (2021)
Open Access | Times Cited: 4
Moran Grossman, Elaine Adler
Biochemistry (2021)
Open Access | Times Cited: 4
Showing 4 citing articles:
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Sunitha Shyam Sunder, Umesh C. Sharma, Saraswati Pokharel
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 191
Sunitha Shyam Sunder, Umesh C. Sharma, Saraswati Pokharel
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 191
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, N. Rajendra Prasad
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 52
Priya Yadav, Suresh V. Ambudkar, N. Rajendra Prasad
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 52
Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3β/Aβ aggregation inhibitor and anti-Alzheimer’s agent
Sukanya Sukanya, Aina Bellver‐Sanchís, Bhanwar Singh Choudhary, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107811-107811
Closed Access | Times Cited: 1
Sukanya Sukanya, Aina Bellver‐Sanchís, Bhanwar Singh Choudhary, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107811-107811
Closed Access | Times Cited: 1
Emerging peptide therapeutics for the treatment of ovarian cancer
Ana Veneziani, Eduardo González-Ochoa, Amit M. Oza
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 129-144
Open Access | Times Cited: 3
Ana Veneziani, Eduardo González-Ochoa, Amit M. Oza
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 129-144
Open Access | Times Cited: 3